Agios Pharmaceuticals (United States)
Agios Pharmaceuticals Inc. is a publicly trading American pharmaceutical company pioneering therapies for genetically defined diseases, with a near-term focus on developing therapies for hemolytic anemias. The company was founded in 2008 by Lewis Cantley, Tak Mak and Craig Thompson. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Agios Pharmaceuticals (United States), United States, covering academic research published from 2009 to 2025. Read More.
Open Access Percentage
51%
Total
Publications
633
Total Open
Publications
322
Total
Citations
51K
Open Access
Percentage
51%
Total
Publications
633
Total Open
Publications
322
Total
Citations
51K
Breakdown
Publisher Open
14%
Both
28%
Other Platform Open
9%
Closed
49%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 42%
110
Hybrid 20%
54
No Guarantees 38%
101
Other Platform Open
Domain 80%
188
Institution 45%
106
Other Internet 9%
21
Preprint 6%
14
Public 2%
5
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 193 |
doaj.org OAI-PMH Repository | Institution | 70 |
DOI | Other Internet | 14 |
bioRxiv | Preprint | 13 |
Unknown Repository | Other Internet | 11 |
Utrecht University | Institution | 10 |
University of Groningen | Institution | 4 |
University of Copenhagen | Institution | 4 |
Harvard University | Institution | 4 |
Figshare | Public | 4 |